Related Experiment Videos
Update on enzyme and molecular defects in porphyria
1Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Photodermatology, Photoimmunology & Photomedicine
|June 25, 1998
Summary
Porphyrias stem from enzyme deficiencies in heme biosynthesis. Genetic analysis offers superior screening for acute intermittent porphyria (AIP) and variegate porphyria (VP), while congenital erythropoietic porphyria (CEP) shows genotype-phenotype links.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Porphyrias are a group of genetic disorders caused by deficiencies in enzymes crucial for heme biosynthesis.
- Understanding the molecular basis of these enzyme deficiencies is key to diagnosing and managing porphyrias.
Purpose of the Study:
- To outline the molecular basis of enzyme deficiencies in acute intermittent porphyria (AIP), variegate porphyria (VP), and congenital erythropoietic porphyria (CEP).
- To explore genotype/phenotype correlations and the utility of mutational analysis versus biochemical methods for screening.
- To investigate the complex genetic underpinnings of porphyria cutanea tarda (PCT).
Main Methods:
- Review of molecular basis for enzyme deficiencies in AIP, VP, and CEP.
- Analysis of allelic heterogeneity and genotype/phenotype correlations.
- Comparison of mutational analysis and biochemical methods for latent porphyria screening.
- Investigation of genetic factors contributing to porphyria cutanea tarda (PCT).
Main Results:
- AIP and VP exhibit extensive allelic heterogeneity with no clear genotype/phenotype correlations and uncertain clinical penetrance.
- Mutational analysis is more effective than biochemical methods for screening AIP and VP families.
- CEP, an autosomal recessive disorder, shows some genotype/phenotype correlation, with a common mutation (C73R) linked to severe disease in homozygotes.
- PCT is multifactorial, involving inherited susceptibility to hepatic uroporphyrinogen decarboxylase (UROD) inactivation, with UROD gene mutations and HFE gene mutations (C282Y) identified as predisposing factors.
Conclusions:
- Genetic analysis is crucial for understanding and managing porphyrias, particularly for screening latent cases of AIP and VP.
- Congenital erythropoietic porphyria (CEP) demonstrates a link between specific genotypes and disease severity.
- Porphyria cutanea tarda (PCT) arises from a complex interplay of genetic predisposition and environmental factors affecting liver function.